Abstract
Summary
Phage Therapy Kits refer to the use of bacteriophages, which are viruses that target and destroy specific bacterial strains, for the treatment of bacterial infections. These kits typically contain a selection of phages that can be used to treat infections that are resistant to antibiotics.
The global Phage Therapy Kits market size is projected to grow from US$ million in 2026 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
LP Information, Inc. (LPI) ' newest research report, the “Phage Therapy Kits Industry Forecast” looks at past sales and reviews total world Phage Therapy Kits sales in 2025, providing a comprehensive analysis by region and market sector of projected Phage Therapy Kits sales for 2026 through 2032. With Phage Therapy Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phage Therapy Kits industry.
This Insight Report provides a comprehensive analysis of the global Phage Therapy Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phage Therapy Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Phage Therapy Kits market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phage Therapy Kits and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phage Therapy Kits.
United States market for Phage Therapy Kits is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Phage Therapy Kits is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Phage Therapy Kits is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Phage Therapy Kits players cover BiomX, PhagoMed Biopharma, Cytophage Technologies, MYRIADE, DotBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Phage Therapy Kits market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Medical Grade
Laboratory Grade
Segmentation by Application:
Medical
Food Industrial
Agriculture
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BiomX
PhagoMed Biopharma
Cytophage Technologies
MYRIADE
DotBio
Snipr Biome
CJ
Intralytix
iNtRON Biotechnology
Micreos
Key Questions Addressed in this Report
What is the 10-year outlook for the global Phage Therapy Kits market?
What factors are driving Phage Therapy Kits market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Phage Therapy Kits market opportunities vary by end market size?
How does Phage Therapy Kits break out by Type, by Application?
The global Phage Therapy Kits market size is projected to grow from US$ million in 2026 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
LP Information, Inc. (LPI) ' newest research report, the “Phage Therapy Kits Industry Forecast” looks at past sales and reviews total world Phage Therapy Kits sales in 2025, providing a comprehensive analysis by region and market sector of projected Phage Therapy Kits sales for 2026 through 2032. With Phage Therapy Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phage Therapy Kits industry.
This Insight Report provides a comprehensive analysis of the global Phage Therapy Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phage Therapy Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Phage Therapy Kits market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phage Therapy Kits and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phage Therapy Kits.
United States market for Phage Therapy Kits is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Phage Therapy Kits is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Phage Therapy Kits is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Phage Therapy Kits players cover BiomX, PhagoMed Biopharma, Cytophage Technologies, MYRIADE, DotBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Phage Therapy Kits market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Medical Grade
Laboratory Grade
Segmentation by Application:
Medical
Food Industrial
Agriculture
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BiomX
PhagoMed Biopharma
Cytophage Technologies
MYRIADE
DotBio
Snipr Biome
CJ
Intralytix
iNtRON Biotechnology
Micreos
Key Questions Addressed in this Report
What is the 10-year outlook for the global Phage Therapy Kits market?
What factors are driving Phage Therapy Kits market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Phage Therapy Kits market opportunities vary by end market size?
How does Phage Therapy Kits break out by Type, by Application?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Phage Therapy Kits Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Phage Therapy Kits by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Phage Therapy Kits by Country/Region, 2021, 2025 & 2032
2.2 Phage Therapy Kits Segment by Type
2.2.1 Medical Grade
2.2.2 Laboratory Grade
2.3 Phage Therapy Kits Sales by Type
2.3.1 Global Phage Therapy Kits Sales Market Share by Type (2021-2026)
2.3.2 Global Phage Therapy Kits Revenue and Market Share by Type (2021-2026)
2.3.3 Global Phage Therapy Kits Sale Price by Type (2021-2026)
2.4 Phage Therapy Kits Segment by Application
2.4.1 Medical
2.4.2 Food Industrial
2.4.3 Agriculture
2.4.4 Others
2.5 Phage Therapy Kits Sales by Application
2.5.1 Global Phage Therapy Kits Sale Market Share by Application (2021-2026)
2.5.2 Global Phage Therapy Kits Revenue and Market Share by Application (2021-2026)
2.5.3 Global Phage Therapy Kits Sale Price by Application (2021-2026)
3 Global by Company
3.1 Global Phage Therapy Kits Breakdown Data by Company
3.1.1 Global Phage Therapy Kits Annual Sales by Company (2021-2026)
3.1.2 Global Phage Therapy Kits Sales Market Share by Company (2021-2026)
3.2 Global Phage Therapy Kits Annual Revenue by Company (2021-2026)
3.2.1 Global Phage Therapy Kits Revenue by Company (2021-2026)
3.2.2 Global Phage Therapy Kits Revenue Market Share by Company (2021-2026)
3.3 Global Phage Therapy Kits Sale Price by Company
3.4 Key Manufacturers Phage Therapy Kits Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Phage Therapy Kits Product Location Distribution
3.4.2 Players Phage Therapy Kits Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Phage Therapy Kits by Geographic Region
4.1 World Historic Phage Therapy Kits Market Size by Geographic Region (2021-2026)
4.1.1 Global Phage Therapy Kits Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Phage Therapy Kits Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Phage Therapy Kits Market Size by Country/Region (2021-2026)
4.2.1 Global Phage Therapy Kits Annual Sales by Country/Region (2021-2026)
4.2.2 Global Phage Therapy Kits Annual Revenue by Country/Region (2021-2026)
4.3 Americas Phage Therapy Kits Sales Growth
4.4 APAC Phage Therapy Kits Sales Growth
4.5 Europe Phage Therapy Kits Sales Growth
4.6 Middle East & Africa Phage Therapy Kits Sales Growth
5 Americas
5.1 Americas Phage Therapy Kits Sales by Country
5.1.1 Americas Phage Therapy Kits Sales by Country (2021-2026)
5.1.2 Americas Phage Therapy Kits Revenue by Country (2021-2026)
5.2 Americas Phage Therapy Kits Sales by Type (2021-2026)
5.3 Americas Phage Therapy Kits Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Phage Therapy Kits Sales by Region
6.1.1 APAC Phage Therapy Kits Sales by Region (2021-2026)
6.1.2 APAC Phage Therapy Kits Revenue by Region (2021-2026)
6.2 APAC Phage Therapy Kits Sales by Type (2021-2026)
6.3 APAC Phage Therapy Kits Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Phage Therapy Kits by Country
7.1.1 Europe Phage Therapy Kits Sales by Country (2021-2026)
7.1.2 Europe Phage Therapy Kits Revenue by Country (2021-2026)
7.2 Europe Phage Therapy Kits Sales by Type (2021-2026)
7.3 Europe Phage Therapy Kits Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Phage Therapy Kits by Country
8.1.1 Middle East & Africa Phage Therapy Kits Sales by Country (2021-2026)
8.1.2 Middle East & Africa Phage Therapy Kits Revenue by Country (2021-2026)
8.2 Middle East & Africa Phage Therapy Kits Sales by Type (2021-2026)
8.3 Middle East & Africa Phage Therapy Kits Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Phage Therapy Kits
10.3 Manufacturing Process Analysis of Phage Therapy Kits
10.4 Industry Chain Structure of Phage Therapy Kits
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Phage Therapy Kits Distributors
11.3 Phage Therapy Kits Customer
12 World Forecast Review for Phage Therapy Kits by Geographic Region
12.1 Global Phage Therapy Kits Market Size Forecast by Region
12.1.1 Global Phage Therapy Kits Forecast by Region (2027-2032)
12.1.2 Global Phage Therapy Kits Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Phage Therapy Kits Forecast by Type (2027-2032)
12.7 Global Phage Therapy Kits Forecast by Application (2027-2032)
13 Key Players Analysis
13.1 BiomX
13.1.1 BiomX Company Information
13.1.2 BiomX Phage Therapy Kits Product Portfolios and Specifications
13.1.3 BiomX Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 BiomX Main Business Overview
13.1.5 BiomX Latest Developments
13.2 PhagoMed Biopharma
13.2.1 PhagoMed Biopharma Company Information
13.2.2 PhagoMed Biopharma Phage Therapy Kits Product Portfolios and Specifications
13.2.3 PhagoMed Biopharma Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 PhagoMed Biopharma Main Business Overview
13.2.5 PhagoMed Biopharma Latest Developments
13.3 Cytophage Technologies
13.3.1 Cytophage Technologies Company Information
13.3.2 Cytophage Technologies Phage Therapy Kits Product Portfolios and Specifications
13.3.3 Cytophage Technologies Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Cytophage Technologies Main Business Overview
13.3.5 Cytophage Technologies Latest Developments
13.4 MYRIADE
13.4.1 MYRIADE Company Information
13.4.2 MYRIADE Phage Therapy Kits Product Portfolios and Specifications
13.4.3 MYRIADE Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 MYRIADE Main Business Overview
13.4.5 MYRIADE Latest Developments
13.5 DotBio
13.5.1 DotBio Company Information
13.5.2 DotBio Phage Therapy Kits Product Portfolios and Specifications
13.5.3 DotBio Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 DotBio Main Business Overview
13.5.5 DotBio Latest Developments
13.6 Snipr Biome
13.6.1 Snipr Biome Company Information
13.6.2 Snipr Biome Phage Therapy Kits Product Portfolios and Specifications
13.6.3 Snipr Biome Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Snipr Biome Main Business Overview
13.6.5 Snipr Biome Latest Developments
13.7 CJ
13.7.1 CJ Company Information
13.7.2 CJ Phage Therapy Kits Product Portfolios and Specifications
13.7.3 CJ Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 CJ Main Business Overview
13.7.5 CJ Latest Developments
13.8 Intralytix
13.8.1 Intralytix Company Information
13.8.2 Intralytix Phage Therapy Kits Product Portfolios and Specifications
13.8.3 Intralytix Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Intralytix Main Business Overview
13.8.5 Intralytix Latest Developments
13.9 iNtRON Biotechnology
13.9.1 iNtRON Biotechnology Company Information
13.9.2 iNtRON Biotechnology Phage Therapy Kits Product Portfolios and Specifications
13.9.3 iNtRON Biotechnology Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 iNtRON Biotechnology Main Business Overview
13.9.5 iNtRON Biotechnology Latest Developments
13.10 Micreos
13.10.1 Micreos Company Information
13.10.2 Micreos Phage Therapy Kits Product Portfolios and Specifications
13.10.3 Micreos Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Micreos Main Business Overview
13.10.5 Micreos Latest Developments
14 Research Findings and Conclusion